Plaintiffs lawyers who are suing drugmaker Pfizer over alleged effects of the antidepressant Zoloft say that the cases shouldn’t be consolidated into a federal multidistrict litigation before a decision is made on whether the cases will be remanded to Pennsylvania state court.
The plaintiffs lawyers, who allege that birth defects were caused in children whose mothers took Zoloft during their pregnancies, asked U.S. District Court Chief Judge J. Curtis Joyner of the Eastern District of Pennsylvania to deny Pfizer’s motion to stay almost 50 Zoloft cases until a decision is made by the U.S. Judicial Panel on Multidistrict Litigation if the Zoloft cases should be consolidated in an MDL.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
